RxDoctor Payments Data

Austin Wise, DO

Internal Medicine · Memphis, TNNPI 1942655097

Payments from drug & device makers

$2,128in general payments, 2019–2025

Across 128 payments — averaging $16.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$569
  • Amgen$328
  • Pfizer$300
  • Lilly USA, LLC$175
  • AstraZeneca$129
  • Dexcom, Inc.$115
  • plus $513 from 10 others

What the payments were for

  • Food & beverage$2,128100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,128 in reported general payments places this provider in the 75th percentile of 2,216 internal medicine providers in Tennessee.

See all internal medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$73,660
Medicare patients
148
Services billed
842

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$84,507
MounjaroTirzepatide43$75,072
EliquisApixaban30$44,332
FarxigaDapagliflozin Propanediol22$33,730
XareltoRivaroxaban15$23,169
TrulicityDulaglutide17$19,535
Repatha SureclickEvolocumab11$17,678
Tresiba Flextouch U-200Insulin Degludec14$15,476
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,427
Atorvastatin Calcium263$3,011
Rosuvastatin Calcium252$2,902
Gabapentin111$2,351
Losartan Potassium176$2,311
Duloxetine Hcl63$1,708
SynthroidLevothyroxine Sodium20$1,639

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$175$94,60760 claims
Novo NordiskOzempic$569$84,50760 claims
PfizerEliquis$300$44,33230 claims
AstraZenecaFarxiga$129$33,73022 claims
Johnson & JohnsonXarelto$105$23,16915 claims
GSKTrelegy Ellipta$15$8,42713 claims
AbbVieSynthroid$16$1,63920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,216 internal medicine providers in Tennessee.

Other internal medicine in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →